title: Second BMT for thalassemia major using CY post transplant.
authors.affiliation: Pakistan Institute of Medical Sciences (PIMS), Islamabad, Pakistan.
authors.forename: N
authors.initials: N
authors.lastname: Yaqub
authors.affiliation: Cure2Children Foundation, Florence, Italy.
authors.forename: S
authors.initials: S
authors.lastname: Khalid
authors.affiliation: Pakistan Institute of Medical Sciences (PIMS), Islamabad, Pakistan.
authors.forename: F
authors.initials: F
authors.lastname: Itrat
authors.affiliation: Pakistan Institute of Medical Sciences (PIMS), Islamabad, Pakistan.
authors.forename: A
authors.initials: A
authors.lastname: Khan
authors.affiliation: Pakistan Institute of Medical Sciences (PIMS), Islamabad, Pakistan.
authors.forename: S K
authors.initials: SK
authors.lastname: Gilani
authors.affiliation: Cure2Children Foundation, Florence, Italy.
authors.forename: M E
authors.initials: ME
authors.lastname: Missiry
authors.affiliation: Cure2Children Foundation, Florence, Italy.
authors.forename: M H
authors.initials: MH
authors.lastname: Hussain
authors.affiliation: Cure2Children Foundation, Florence, Italy.
authors.forename: C
authors.initials: C
authors.lastname: Uderzo
authors.affiliation: Cure2Children Foundation, Florence, Italy.
authors.forename: L
authors.initials: L
authors.lastname: Faulkner
mesh_terms: D016026:Bone Marrow Transplantation / Q000379:methods*; D002675:Child, Preschool; D003520:Cyclophosphamide / Q000008:administration & dosage*; D006086:Graft vs Host Disease / Q000517:prevention & control; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D007223:Infant; D008297:Male; D019653:Myeloablative Agonists / Q000008:administration & dosage; D019172:Transplantation Conditioning / Q000379:methods; D017086:beta-Thalassemia / Q000188:drug therapy* / Q000628:therapy*
chemical_list: D007166:Immunosuppressive Agents; D019653:Myeloablative Agonists; D003520:Cyclophosphamide